Literature DB >> 786893

Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin.

C M Cunningham, E L Barsumian, D W Watson.   

Abstract

Streptococcal pyrogenic exotoxin (SPE) isolated from culture filtrates of strain NY-5 (type 10), and separated from other extracellular by differential solubility in ethanol and acetate-buffered saline, has previously been shown to exhibit a wide range of biological activities including erythrogenic activity, pyrogenicity, enhancement of susceptibility to endotoxin shock, blockage of the reticuloendothelial system immmunosuppression, and lymphocyte mitogenicity. Toxin prepared in this way was found to consist of hyaluronic acid and several proteins which could be distinguished by thin-layer polyacrylamide isoelectric focusing (IEF), SPE has been further purified by ion exchange chromatography on QAE-Sephadex columns. One of the fractions isolated from QAE-Sephadex, and shown to be a homogenous protein by thin-layer IEF and Ouchterlony with hyperimmune serum, was highly active erythrogenically, pyrogenically, and in enhancing susceptibility to endotoxin. This fraction was identified as exotoxin A. A second, less active fraction identified as SPE B showed similar activities, but differed from the other fraction antigenically and in net charge and molecular weight. These findings indicate that a single highly purified protein can mediate at least three of the biological activities attributed to SPE and NY-5 produces pyrogenic exotoxins A and B in vitro as well as in vivo.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786893      PMCID: PMC420952          DOI: 10.1128/iai.14.3.767-775.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS.

Authors:  D A YPHANTIS
Journal:  Biochemistry       Date:  1964-03       Impact factor: 3.162

2.  Chemical properties of streptococcal proteinase and its zymogen.

Authors:  T Y LIU; N P NEUMANN; S D ELLIOTT; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

3.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  Lymphocyte-stimulating activity of scarlet fever toxin.

Authors:  V Hríbalová; M Pospísil
Journal:  Experientia       Date:  1973-06-15

5.  The reaction of carbazole with carbohydrates. I. Effect of borate and sulfamate on the carbazole color of sugars.

Authors:  J T Galambos
Journal:  Anal Biochem       Date:  1967-04       Impact factor: 3.365

6.  Thin-layer isoelectric focusing of proteins.

Authors:  B J Radola
Journal:  Biochim Biophys Acta       Date:  1969-11-11

7.  Evidence for two molecular forms of streptococcal erythrogenic toxin. Conversion to a single form by 2-mercaptoethanol.

Authors:  C Nauciel; J Blass; R Mangalo; M Raynaud
Journal:  Eur J Biochem       Date:  1969-11

8.  HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS.

Authors:  E E HANNA; D W WATSON
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

9.  Electrophoretic studies of the extracellular products of group A Streptococci.

Authors:  L W WANNAMAKER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  30 in total

1.  Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor.

Authors:  A R Hauser; P M Schlievert
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

2.  A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant.

Authors:  E M Mascini; M A Hazenberg; L A Verhage; S E Holm; J Verhoef; H van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains.

Authors:  C E Yu; J J Ferretti
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

5.  Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production.

Authors:  L P Johnson; M A Tomai; P M Schlievert
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

6.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.

Authors:  J B Kline; C M Collins
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.

Authors:  D A Weigent; E H Beachey; T Huff; J W Peterson; G J Stanton; S Baron
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.